fbpx

Bad Drugs

Tag Archive

Who Can Be Held Liable for Defective Medication?

Who Can Be Held Liable for Defective Medication?

| Pharmaceutical Litigation
Millions of people in America take medication every day to treat different types of illnesses. While most pharmaceutical drugs are safe, there is always the chance of defective medication making its way to the market. If you have suffered an injury or illness after taking defective medication, you can claim compensation for an injury through…Read the article
Did Zantac Cause My Cancer? How to Know

Did Zantac Cause My Cancer? How to Know

| Pharmaceutical Litigation
Zantac is one of the brand names of ranitidine, a generic medicine. It’s one of the many medications used to treat the symptoms of acid reflux, also known as gastroesophageal reflux disease (GERD), or heartburn. However, some patients develop cancer symptoms while or after using the drug. Zantac can be cancer causing, and the Federal…Read the article
FDA Issues New Xeljanz Warning

FDA Issues New Xeljanz Warning

| Pharmaceutical Litigation
For the third time in two years, the Food and Drug Administration has issued a safety warning about Pfizer’s powerful and popular arthritis/UC medicine. The latest warning is the strongest and most comprehensive one yet. The FDA says that doses as small as 5mg per day could lead to cancer and heart problems, particularly among…Read the article
FDA Finds Cancer-Causing Agent in Metformin

FDA Finds Cancer-Causing Agent in Metformin

| Pharmaceutical Litigation
The sudden recall of a popular diabetes drug because of NDMA contamination (cancer-causing agent) creates a cloud over the Food and Drug Administration’s entire review process. Time-Cap Labs Inc.’s generic drug is used to treat Type 2 diabetes. Its lower cost makes it a popular alternative to brand-name drugs. When the most recent test results…Read the article
Warned: Non-Medical COVID-19 Treatment Producers

Warned: Non-Medical COVID-19 Treatment Producers

| Pharmaceutical Litigation
The Federal Trade Commission and Food and Drug Administration recently told seven companies to either stop selling certain products or revise their claims. In a mass letter to Vital Silver, GuruNanda, LLC, Vivify Holistic Clinic, Herbal Amy LLC, Quinessence Aromatherapy Ltd., Xephyr, LLC doing business as N-Ergetics, and The Jim Baker Show, regulators said these…Read the article
Medtronic Recalls Faulty Insulin Pumps

Medtronic Recalls Faulty Insulin Pumps

| Pharmaceutical Litigation
After evidence of a possible life-threatening defect came to light, Medtronic, the medical device giant issued an immediate recall for its MiniMed Insulin Pumps. The recall covers over 300,000 devices which were sold in the United States beginning in June 2017. Medtronic touted these pumps as safe to use for people as young as seven…Read the article
Coronavirus Leads to More Drug Overdose Deaths

Coronavirus Leads to More Drug Overdose Deaths

| Opioid Crisis
The coronavirus outbreak is making yet another serious problem even worse, fatal drug overdose deaths are up 50 percent in Nassau County, and other nearby jurisdictions report similar statistics. Nassau County Police Commissioner Patrick Rydersaid the spike is due to people self-medicating with a combination of painkillers and alcohol. “People are out of work, people…Read the article
Bladder Medication Can Cause Blindness

Bladder Medication Can Cause Blindness

| Pharmaceutical Litigation
Orphan drug affects eyesight Having been widely prescribed for decades, the Elmiron bladder medication has recently been found to be toxic to the retina (damage). An article published by the American Academy of Ophthalmology in 2018 described six patients experiencing pigmentary maculopathy after chronic exposure to Elmiron (pentosan polysulfate sodium) for interstitial cystitis. The following…Read the article
Government Recalls Diabetes Drug

Government Recalls Diabetes Drug

| Pharmaceutical Litigation
After government inspectors found traces of a cancer-causing chemical in Metformin, the Food and Drug Administration ordered a recall of one of the most commonly-prescribed diabetes drugs in America. FDA officials discovered a dangerous chemical, N-Nitrosodimethylamine, in five different Metformin versions. About 34 million Americans have Type 2 Diabetes, and many of them take some…Read the article
Prescription Weight Loss Drug Pulled Off The Market

Prescription Weight Loss Drug Pulled Off The Market

| Pharmaceutical Litigation
In 2012, the FDA approved the first new prescription weight loss drug in thirteen years: lorcaserin, marketed as Belviq. Available to patients in the US since June 2013 in a twice-daily dose, it was soon (2016) followed by once-a-day Belviq XR. Expectations crushed Nevertheless, this herald of hope for almost one third of Americans rated…Read the article